What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Disease
- Surgery
The scientist’s investigation covers issues in Internal medicine, Arthritis, Rheumatology, Physical therapy and Clinical trial.
His studies link Surgery with Internal medicine.
His Arthritis study combines topics in areas such as Systematic review and Intensive care medicine.
His Rheumatology research includes themes of Rheumatism, El Niño, Tuberculosis and Family medicine.
His work carried out in the field of Physical therapy brings together such families of science as Polymyositis, Dermatomyositis, Juvenile Arthritis Disease Activity Score and Adult dermatomyositis.
His Clinical trial study combines topics from a wide range of disciplines, such as Fibromyalgia, Juvenile dermatomyositis, Chronic pain, Coping and Cognitive behavioral therapy.
His most cited work include:
- Recommendations for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis (787 citations)
- De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases. (560 citations)
- 2011 American College of Rheumatology Recommendations for the Treatment of Juvenile Idiopathic Arthritis: Initiation and Safety Monitoring of Therapeutic Agents for the Treatment of Arthritis and Systemic Features (544 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Internal medicine, Arthritis, Rheumatology, Physical therapy and Immunology.
Daniel J. Lovell interconnects Placebo and Surgery in the investigation of issues within Internal medicine.
Daniel J. Lovell does research in Arthritis, focusing on Juvenile rheumatoid arthritis specifically.
His study looks at the relationship between Rheumatology and topics such as Disease, which overlap with Intensive care medicine and Psychological intervention.
His research in Physical therapy focuses on subjects like Clinical trial, which are connected to Randomized controlled trial.
His Immunology research includes elements of Safety profile and Gene expression.
He most often published in these fields:
- Internal medicine (64.34%)
- Arthritis (52.57%)
- Rheumatology (33.46%)
What were the highlights of his more recent work (between 2018-2021)?
- Internal medicine (64.34%)
- Arthritis (52.57%)
- Rheumatology (33.46%)
In recent papers he was focusing on the following fields of study:
Daniel J. Lovell mostly deals with Internal medicine, Arthritis, Rheumatology, Cohort and Tocilizumab.
His Placebo research extends to Internal medicine, which is thematically connected.
His Placebo research is multidisciplinary, incorporating perspectives in Psychosocial, Quality of life, Randomized controlled trial and Clinical trial.
His Arthritis research integrates issues from Juvenile, Methotrexate, Juvenile Arthritis Disease Activity Score and Pediatrics.
His Rheumatology study incorporates themes from Orthopedic surgery, Tuberculosis, Retrospective analysis and Enthesitis.
His Cohort study also includes
- Retrospective cohort study which intersects with area such as Prevalence and Pharmacotherapy,
- Disease burden most often made with reference to Down syndrome.
Between 2018 and 2021, his most popular works were:
- Toward New Classification Criteria for Juvenile Idiopathic Arthritis : First Steps, Pediatric Rheumatology International Trials Organization International Consensus (84 citations)
- 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Non-Systemic Polyarthritis, Sacroiliitis, and Enthesitis (51 citations)
- 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis–Associated Uveitis (41 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Surgery
His primary areas of study are Arthritis, Internal medicine, Rheumatology, Family medicine and Polyarthritis.
His Arthritis research is multidisciplinary, relying on both Discontinuation, Juvenile Arthritis Disease Activity Score and Cohort.
Daniel J. Lovell connects Internal medicine with Data collection in his research.
The study incorporates disciplines such as MedDRA, Pharmacovigilance, Pediatric Infectious Disease and Orthopedic surgery in addition to Rheumatology.
His research in Family medicine tackles topics such as Pediatric rheumatology which are related to areas like Clinical trial, New medications, Paediatric rheumatology and Clinical study design.
His Polyarthritis research focuses on Cohort study and how it relates to Cross-sectional study, Oligoarthritis, Disease burden and Retrospective cohort study.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
